With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus||Research Institute at Nationwide Children's Hospital / Kevin Cassady, MD & Christopher Walker, PhD||Innovation Grants||2016||Ohio|
|Detection of Circulating Tumor DNA in Pediatric Sarcomas||The Regents of the University of California San Francisco / Alejandro Sweet-Cordero, MD & Maximillian Diehn, MD/PhD (Stanford University)||Innovation Grants||2016||California|
|Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia||University of Rochester / Craig Mullen, MD/PhD||Innovation Grants||2016||New York|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|Micro-environmental Regulators of Ewing sarcoma Metastasis||University of Pittsburgh / Kelly Bailey, MD/PhD||Young Investigator Grants||2016||Pennsylvania|
|Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Melinda Biernacki, MD||Young Investigator Grants||2016||Washington|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|
|The Role of MiRNA Impairment in Wilms' Tumor Formation||University of Texas Southwestern Medical Center at Dallas / Kenneth Chen, MD||Young Investigator Grants||2016||Texas|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|